Compare HRMY & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | DNUT |
|---|---|---|
| Founded | 2017 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 734.9M |
| IPO Year | 2020 | 2021 |
| Metric | HRMY | DNUT |
|---|---|---|
| Price | $40.55 | $4.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $51.33 | $6.22 |
| AVG Volume (30 Days) | 765.2K | ★ 3.4M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.59% |
| EPS Growth | ★ 50.44 | N/A |
| EPS | ★ 3.17 | N/A |
| Revenue | $825,944,000.00 | ★ $1,534,272,000.00 |
| Revenue This Year | $23.11 | N/A |
| Revenue Next Year | $16.15 | $0.77 |
| P/E Ratio | $12.79 | ★ N/A |
| Revenue Growth | ★ 21.13 | N/A |
| 52 Week Low | $25.52 | $2.50 |
| 52 Week High | $40.93 | $10.40 |
| Indicator | HRMY | DNUT |
|---|---|---|
| Relative Strength Index (RSI) | 80.09 | 58.08 |
| Support Level | $38.12 | $4.19 |
| Resistance Level | $40.00 | $4.75 |
| Average True Range (ATR) | 1.20 | 0.22 |
| MACD | 0.25 | 0.03 |
| Stochastic Oscillator | 100.00 | 70.18 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.